Guide · Public documents checked September 27, 2026
Niacinamide, zinc oxide, urea and salicylic acid: reading one cream’s ingredient claims
Four named ingredients provide a starting point for questions, not four separate proofs that the finished product works.
Editorial source review, with no clinician sign-off or firsthand treatment experience claimed.
A multi-ingredient cream can sound complete before its label has been read. One ingredient is described as clearing pores, another as calming, and another as smoothing. The story is easy to understand. What it does not reveal is whether the exact mixture has been tested for the outcome being promised, or whether the public description lists everything in the preparation.
Pore Favor is the example here because its offer names salicylic acid, niacinamide, zinc oxide and urea. Surface Sense is a CoreAge Rx promotional publishing network publication, with CoreAge’s first commercial position openly disclosed. The ingredient discussion does not make that placement a medical ranking or turn the seller’s explanation into independent product evidence.
In this article
Write down what is actually advertised
The current CoreAge offer identifies salicylic acid at 2% and niacinamide at 8% in its plan descriptions. Elsewhere on that same page it identifies zinc oxide at 5% and urea at 2%. These are advertised formula details checked on September 27, 2026. They should be attributed to the offer rather than described as our laboratory measurements. Pore Favor offer
The product page calls the preparation a cream; the offer also uses the broader term lightweight topical. Neither term supplies the full base composition. The CoreAge review brings the product identity, sales terms and unresolved package details together without inventing a missing ingredient panel.
Distinguish a proposed role from a demonstrated result
The company links salicylic acid with congestion, niacinamide and zinc oxide with a calmer or more balanced appearance, and urea with smoother-feeling texture. These descriptions explain its proposed formulation rationale. They do not establish how much each ingredient contributes to a finished-product result or whether the ingredients improve one another's effects.
AAD's adult-acne guidance discusses salicylic acid as an ingredient that helps unclog pores and exfoliate skin. That supports a general ingredient explanation, not a clinical conclusion about this four-part compounded formula. A study of a different concentration, vehicle or population would need its own limits stated before being used here. AAD adult-acne guidance
Active and inactive are label categories
FDA explains that the active-ingredient part of an OTC Drug Facts label identifies substances responsible for the intended therapeutic effect, while other sections describe purpose, uses, warnings and inactive ingredients. The structure helps readers understand the medicine. It is not a list ranking every ingredient by its marketing importance. FDA Drug Facts guide
For example, the CeraVe Acne Control Cleanser record identifies salicylic acid as its active ingredient and lists niacinamide among inactive ingredients. That does not establish the amount of niacinamide or a comparison with Pore Favor's advertised percentage. It also does not make the two complete products equivalent. CeraVe drug record
The complete list can change the question
A headline formula may name selected ingredients while leaving the vehicle and other components unspecified. Those omissions matter when someone has an ingredient concern or needs the exact product documented. “Contains niacinamide” answers a narrower question than “What is everything in this dispensed preparation?”
The CeraVe manufacturer page and its posted drug record illustrate another issue: their inactive-ingredient lists differ. The correct response is to identify the actual package version, not silently choose whichever list looks more familiar. FDA also notes that manufacturers can change product ingredients or labeling. The cream-versus-cleanser guide explains why full names and current labels belong together. CeraVe manufacturer page
Zinc oxide does not supply an SPF number
Zinc oxide can be an ingredient in a sunscreen, but finding its name and percentage in a different preparation does not establish that preparation's tested sun-protection factor. FDA explains that sunscreen SPF is determined by testing the sunscreen product. Broad-spectrum protection is also a specific label claim, not something supplied by an ingredient name alone. FDA sunscreen explanation
Pore Favor's public description does not provide a verified SPF or broad-spectrum result for the finished formula. Its zinc oxide claim therefore cannot replace the separate question of sun protection. The sunscreen-label guide examines the information that would be needed, without estimating protection from the advertised ingredient percentage.
Compounded status is a separate evidence boundary
CoreAge explicitly describes Pore Favor as compounded and states that it is not FDA-approved. FDA explains that compounded drugs are not reviewed for safety, effectiveness and quality through the approval process used for approved drugs. This is a regulatory distinction; it does not establish that every compounded preparation will cause harm or that a particular batch has failed a test. FDA compounding explanation
A licensed-provider claim is likewise different from published testing of a finished formula. Useful unanswered questions concern the precise pharmacy label and any relevant product-specific evidence. The absence of that evidence in the records reviewed here should stay visible rather than being filled with reassurance based on familiar ingredients.
Ask for the record that fits the claim
An ingredient question needs an ingredient record. A question about irritation needs an appropriately qualified professional's assessment of the product and circumstances. A comparative effectiveness claim needs comparative evidence. Keeping these requests separate prevents a long ingredient list from being mistaken for an answer to all three.
The fixed format and label reader shows this separation without calculating strength or scoring formulas. Our commercially disclosed comparison follows the same evidence limits. More named ingredients are neither proof of a better result nor proof that a simpler product is preferable. The useful task is to identify what the available record can support and what still requires clarification.
Sources behind this reading
- CoreAge Rx Pore Favor current offer ↗Provider offer page · Checked 2026-09-27
- American Academy of Dermatology: adult acne treatment ↗Medical society patient guidance · Checked 2026-09-27
- FDA: The Over-the-Counter Drug Facts Label ↗Regulator explanation of OTC label fields · Checked 2026-09-27
- CeraVe Acne Control Cleanser drug label ↗L’Oreal US OTC label record; updated March 28, 2025; package-version limits · Checked 2026-09-27
- CeraVe Acne Control Cleanser: exact US product ↗Manufacturer product page · Checked 2026-09-27
- FDA: sunscreen labels and sun protection ↗Current regulator consumer guidance · Checked 2026-09-27
- FDA: compounding questions and answers ↗Regulator explanation · Checked 2026-09-27